Perioperative medicine & outcomes

Patient‐reported outcomes, postoperative pain and pain relief after day‐case surgery ( POPPY ): baseline data from day surgery practice in the UK

AnaesthesiaPublished Prospective observational cohort study

Authors' conclusion

In the UK, over a third of patients presenting for day-case surgery are in pain, which is mostly chronic in duration. One in four have access to opioid medications and a little over one in 10 are using opioids daily.

Study context

Population
Adults undergoing day-case surgery in the UKeligible after exclusions
Participants
7,839 adults
Outcome
Baseline characteristics of day-case surgery patients: pre-existing pain, daily opioid use, treatment for depression/anxiety, and unplanned admission
Follow-up
Baseline
Methodological detailsbaseline data, UK-wide, multicentre
  • Baseline data
  • UK-wide
  • Multicentre

Main finding

As reported in the abstract

Unplanned admission following surgery (most common reason for exclusion)
1131/9618 (11.8%)
Pain at the site of proposed surgery
3060/7839 (39%)
Chronic pain at the site of proposed surgery
2387/7839 (30.5%)
Opioids taken at least daily
885/7839 (11.3%)
Receiving treatment for depression
1109/7839 (14.1%)
Receiving treatment for anxiety
1039/7839 (13.3%)
Anxiety or depression rated moderate or worse
1002/7839 (12.8%)

Observational data: associations, not effects.

Further findings

Unplanned admission after surgery (most common reason for exclusion)

Unplanned admission
1131/9618 (11.8%)
More likely with increasing surgical magnitude, frailty and higher ASA physical status
Some common operations had admission rates of > 50%

Original publication

Patient‐reported outcomes, postoperative pain and pain relief after day‐case surgery ( POPPY ): baseline data from day surgery practice in the UK. Anaesthesia. Published 7 January 2026. doi:10.1111/anae.70055

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.